| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |